Conformis Inc(CFMS) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

ConforMIS, Inc. is a medical technology company, which engages in the development, manufacture, and sale of joint replacement implants. The company is headquartered in Billerica, Massachusetts and currently employs 268 full-time employees. The firm uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient's anatomy. The firm's iFit technology platform is applicable to various joints. The company offers a line of customized knee implants designed to restore the natural shape of a patient's knee. The company offers iTotal CR, which is a total knee replacement implant. Its iFit technology platform consists of three elements, including iFit Design, its algorithms and computer software that is used to design customized implants and associated single-use patient-specific instrumentation referred to as iJigs, based on computed tomography scans of the patient and to prepare a surgical plan customized for the patient (iView); iFit Printing, which is a three-dimensional printing technology used to manufacture iJigs, and iFit Just-in-Time manufacturing and delivery capabilities.

Current Price

$0.82

RSI

35.097

Beta:

1.260341

March 04, 2021
26.3M
-4.3M

-12.008 %
11.781 %
-21.649 %
24.693 %

$68,761,000
$77,429,000
$89,789,000
$78,115,000
$79,899,000
$66,887,000
-12.606 %
-15.963 %
14.945 %
-2.284 %
19.454 %

$-24,251,000
$-28,433,000
$-43,304,000
$-53,418,000
$-57,525,000
$-57,205,000
17.245 %
52.302 %
23.356 %
7.688 %
-0.556 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.